About Hoechst Pakistan Ltd. 
Hoechst Pakistan Ltd.
Pharmaceuticals & Biotechnology
Sanofi-Aventis Pakistan Limited (Sanofi) is a Pakistan-based company, which is engaged in the manufacturing and selling of pharmaceutical and consumer products. The Company's segment is manufacturing and selling of pharmaceutical and consumer products. The Company offers medicines, consumer healthcare products, generics and animal health products. Its products include oral anti-diabetics, such as Amaryl and Amaryl M, Daonil and Daonil - M, and Neodipar; insulins, such as Lantus, Apidra and SoloSTAR; cancer, such as Jevtana, Taxotere, Eloxatin and Fludara; pain management, such as No-Spa, Gardan, Muscoril and Profenid; allergy management, such as Telfast, Avil, Nasacort, Phenergan and Avomine; cough and cold, such as Rhinathiol and Tixylix; sleep disorders, such as Stilnox; emergency care, such as Haemaccel; cardiology, such as Plavix, CoPlavix, Aprovel, Co Aprovel, Clexane, Tritace, Co Tritacem and Winstor, and antibiotics, such as Tarivid, Claforan, Aventriax and Rulid.
Company Coordinates 
Company Details
Plot No. 23, Sector No. 22, Korangi Industrial Area, KARACHI None : 74900
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Syed Babar Ali
Chairman, Independent Non-Executive Director
Mr. Yasser Pirmuhammad
Chief Financial Officer, Director
Amanullah Khan
Executive Director, Director Medical / APH
Ms. Naira Adamyan
Director
Dr. Pius Hornstein
Director
Mr. Shakeel Mapara
Director
Francois Briens
Non-Executive Director
Jean-Marc Georges
Non-Executive Director
Revenue and Profits:
Net Sales:
8,720 Million
(Quarterly Results - Jun 2025)
Net Profit:
790 Million
Pharmaceuticals & Biotechnology
PKR 42,560 Million (Mid Cap)
17.00
NA
2.50%
-0.34
38.26%
5.69






